Isatuximab

Isatuximab, also known by the brand name Sarclisa, is a specific type of medicine used to treat multiple myeloma. It works by targeting a protein called CD38, which acts like a unique marker found on the surface of multiple myeloma cells. By connecting to this marker, Isatuximab helps your body's immune system recognize and eliminate these cancer cells. Learning about this medicine can help you understand your treatment plan and what to expect. This topic provides information and support regarding Isatuximab and its role in your care.